MedPath

PERSICO ANTONIO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.

Not Applicable
Conditions
Phelan-McDermid Syndrome
Autism Spectrum Disorder
First Posted Date
2020-03-18
Last Posted Date
2020-03-18
Lead Sponsor
Antonio Persico
Target Recruit Count
200
Registration Number
NCT04312152
Locations
🇮🇹

Interdipartimental Program "Autismo 0-90" at "G. Martino" Universitary Hospital, Messina, ME, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.